[18F]VM4-037
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for [18F]VM4-037, covering 2013-01-25 to 2014-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Imaging Studies of Kidney Cancer Using 18F-VM4-037 [Phase 2]